InSite Vision,Inc.(OTC:INSV) is not the regular type penny stock company. Unlike most of them, it can maintain stability on the stock market for months, let alone the balance sheet includes figures rarely seen in the penny stock world, except in forums and vague predictions about future results. Yet, again like most penny stock companies, Insite shares similar problems which are hard to ignore. 
Since January, the stock has almost doubled in price with sound trading volumes taking place most of the time. What is more, activity on the market was a result of the company presentations and announcements, rather than of speculative paid stock promotions. Maybe this is one reason why instead of following a pattern of sharp increase and decline, the stock slowly and steadily accumulated value over the past several weeks.
Now, the bad news for traders, figuratively speaking, is that more clarity related to the future of the company is expected in May. InSite Vision would present data regarding its clinical trials, thus information regarding its products. It is still a good month and a half until then and yet to see whether the stock can keep up its current pace. [BANNER]
As mentioned, Insite is not the usual penny stock company with very little cash at hand and no revenues. On the contrary, the figures in the SEC filings are in millions. Nevertheless, there is a common feature that it shares with the other OTC enterprises. This is the ratio of assets, liabilities, revenues and accumulated deficit. The last 10-K statement with period ending Dec. 31, 2010 for example reveals the following:
- total revenues of $11.8 million for 2010, compared to $9.7 million for 2009;
- total current assets of over $19 million;
- total current liabilities of over $65 million;
- accumulated deficit of over $192 million;
- net loss of $9.5 million;
It is obvious that investors have faith in this company, this is why its stock enjoys a good deal of interest during most sessions. Yet, the above numbers are not quite optimistic, and unlike the tendency on the stock market, they get worse on an annual basis.
This is just one reason why intense trading would follow in May. Shareholders expect results and the future direction of the stock price depends on what the company would show in its presentations at the conference in several weeks.
